{
    "created_at": "2020-06-11 13:42:46+00:00",
    "id": 1271075403059388416,
    "text": "@DrSeaPerle @ScottGottliebMD @steveusdin1 @Novavax Novavax will release their Phase 1 trial results on 130 humans in July. They are using a well established protocol of making a pre-fusion Covid spike protein through expression of recombinant insect cells and an adjuvant that enhances immune response.",
    "entities": {
        "mentions": [
            {
                "start": 0,
                "end": 11,
                "username": "DrSeaPerle",
                "id": "1253784705096454158"
            },
            {
                "start": 12,
                "end": 28,
                "username": "ScottGottliebMD",
                "id": "40156330"
            },
            {
                "start": 29,
                "end": 41,
                "username": "steveusdin1",
                "id": "371790609"
            },
            {
                "start": 42,
                "end": 50,
                "username": "Novavax",
                "id": "2913798339"
            }
        ]
    },
    "source": "Twitter for iPad",
    "in_reply_to_user_id": 1253784705096454158
}